Chargement en cours...
The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
Natalizumab, a monoclonal antibody that blocks lymphocyte infiltration in the central nervous system, is a valuable tool in the treatment of relapsing forms of multiple sclerosis (MS). In a phase III clinical trial comparing natalizumab with placebo over 2 years, natalizumab reduced annualized relap...
Enregistré dans:
| Publié dans: | Ther Adv Neurol Disord |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557182/ https://ncbi.nlm.nih.gov/pubmed/28861122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285617716002 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|